Quick Facts for Tevimbra 100mg Injection
- Chemical Class
- Monoclonal Antibody (Humanized IgG4)
- Habit Forming
- No
- Therapeutic Class
- Anti-Cancer (Oncology / Immunotherapy)
- Action Class
- PD-1 Inhibitor / Immune Checkpoint Inhibitor
Composition of Tevimbra 100mg Injection
- Tislelizumab (100mg)
Uses of Tevimbra 100mg Injection
- Treatment of Stomach cancer
- Treatment of Esophageal cancer
Side Effects of Tevimbra 100mg Injection
- Increased glucose level in blood
- Decreased hemoglobin
- Decreased white blood cell count (lymphocytes)
- Decreased sodium level in blood
- Low albumin level in blood
- Anemia (low number of red blood cells)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Weight loss
- Cough
- Increased liver enzymes
Safety Advice for Tevimbra 100mg Injection
- Alcohol (CONSULT YOUR DOCTOR): It is not known whether it is safe to consume alcohol with Tevimbra 100mg Injection. Please consult your doctor.
- Pregnancy (CONSULT YOUR DOCTOR): Tevimbra 100mg Injection is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
- Breast Feeding (CONSULT YOUR DOCTOR): Information regarding the use of Tevimbra 100mg Injection during breastfeeding is not available. Please consult your doctor.
- Driving (CONSULT YOUR DOCTOR): Tevimbra 100mg Injection may cause side effects that could affect your ability to drive.
- Kidney (CONSULT YOUR DOCTOR): Tevimbra 100mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.
- Liver (CONSULT YOUR DOCTOR): There is limited data available on the use of Tevimbra 100mg Injection in patients with liver disease.
Tevimbra 100mg Injection
Inclusive of all taxes
Free Express Cold-Chain Delivery
Temperature-controlled dispatch across India within 4 to 24 hours.
Order through WhatsAppFinancial Assistance Available
Contact our oncology support team to check your eligibility for manufacturer patient assistance programs (PAP) for Tevimbra 100mg Injection.
About this medicine
Tevimbra 100mg Injection (Tislelizumab (100mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Tevimbra 100mg Injection is an anti-cancer immunotherapy used to treat esophageal and gastric (stomach) cancers. It improves the immune system by blocking the PD-1 pathway, helping immune cells detect and destroy cancer cells more effectively. Adhering to the This medicine treatment is essential for its effectiveness. It is given as an IV infusion, usually every few weeks, under medical supervision. Skipping doses or delaying treatment may reduce its benefits. Attend all appointments and inform your doctor of any side effects or new symptoms. Regular monitoring may be needed to track your response and adjust the treatment if required. Common side effects of This medicine can be fatigue, muscle or joint pain, cough, and weight loss. Some patients may experience changes in blood test results, including low hemoglobin, decreased lymphocyte or sodium levels, elevated blood sugar, or elevated liver enzymes. Some have even seen anemia and low albumin levels. These side effects are generally controllable, but frequent follow-up visits and blood tests are necessary to monitor your body's response to the medication. This medicine must not be taken by a person who has experienced a severe reaction to this drug or one of its ingredients. People with active autoimmune diseases, liver conditions, or past organ transplants must tell their doctor before treatment. Frequent blood tests must be done to check liver function, counts of blood cells, and electrolytes. It should be avoided by pregnant women or those planning to become pregnant, as it can harm the unborn child. Always talk to your doctor regarding your entire medical history before initiating this therapy.
Quick Facts
Generic Name
Tislelizumab (100mg)
Dosage Form
Solution
Prescription Status
Doctor's Rx Required
Uses of Tevimbra 100mg Injection
Side Effects of Tevimbra 100mg Injection
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Tevimbra 100mg Injection
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Tevimbra 100mg Injection.
It is not known whether it is safe to consume alcohol with Tevimbra 100mg Injection. Please consult your doctor.
Tevimbra 100mg Injection is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Information regarding the use of Tevimbra 100mg Injection during breastfeeding is not available. Please consult your doctor.
Tevimbra 100mg Injection may cause side effects that could affect your ability to drive.
Tevimbra 100mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.
There is limited data available on the use of Tevimbra 100mg Injection in patients with liver disease.
Cold-Chain Temperature Protocol
Temperature-controlled cold-chain dispatch for Tevimbra 100mg Injection across India, with express delivery in Delhi NCR, Noida, and Ghaziabad.
Temperature Monitoring
Sourced from certified cold-storage warehouses.
Insulated Transit
Dispatched in gel-ice thermal insulated boxes.
Rx Verification
Prescription validated prior to cold dispatch.
Frequently Asked Questions
Clinical Overview: Tevimbra 100mg Injection
Tevimbra 100mg Injection contains Tislelizumab, an advanced humanized monoclonal antibody known as an immune checkpoint inhibitor. It is designed to harness the body's own immune system to recognize and fight cancer cells more effectively, providing a targeted option for specific advanced malignancies.
How It Works (Mechanism of Action)
Cancer cells sometimes evade detection by binding to receptor proteins on immune cells, such as PD-1, effectively putting the immune system to 'sleep.' Tevimbra works by binding specifically to the PD-1 receptor and blocking this interaction. By lifting this blockade, it reactivates your T-cells so they can target, track down, and destroy cancer cells.
Therapeutic & Treatment Context
Oncologists prescribe Tevimbra for various advanced or metastatic cancers, including esophageal squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors as indicated by clinical guidelines, often used either alone or alongside standard chemotherapy.
Important Clinical Information & Precautions
Tevimbra is a specialized biologic infusion administered strictly under the supervision of a qualified medical oncologist in a clinical setting. Because it revs up your immune system, it can occasionally cause immune-related side effects involving organs like the lungs, liver, colon, or endocrine glands. Promptly report any new or worsening symptoms to your healthcare team.
Storage & Safe Handling Instructions
This biologic medicine requires strict cold-chain maintenance. It must be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). Do not freeze or shake the vial. Keep it in its original outer carton to protect it from light until it is ready for preparation.
Dosage & Administration Guidelines
Tevimbra is administered exclusively as an intravenous (IV) infusion by a trained medical professional. The dosage and frequency are carefully calculated by your oncologist based on your specific condition and body weight, typically given once every 2 to 3 weeks.
Authoritative References & Medical Sources
- FDA/EMA Clinical Overview for Tislelizumab (Tevimbra)US FDAView Source
- NCCN Clinical Practice Guidelines in Oncology: Immunotherapy Checkpoint InhibitorsNCCNView Source
Medical information standards
Educational product information for Tevimbra 100mg Injection. Not a substitute for advice from your treating doctor or healthcare provider.
- Reviewed by
- Nitin Kumar, D.Pharm (UPPC Reg: 63405)Lead Registered Pharmacist · 11 years clinical experience · Drug licence RLF21DL2025001406, RLF20DL2025001420. See our medical review policy.
- Content dates
- Catalogue copy is re-checked under our editorial standards. Pricing and stock update more often at checkout.
- Business address
- Vyloo Technologies Pvt. Ltd.
10251, F/F, Library Road, Nawab Ganj, Delhi G.P.O., Delhi, North Delhi- 110006, Delhi, IndiaGSTIN 07AAKCV0933E1ZF, 09AAKCV0933E1ZB. More on our drug licence page.
Authoritative references
- CDSCO (India) — Central Drugs Standard Control Organisation — Indian drug regulator
- Ministry of Health & Family Welfare — Government of India health ministry
- WHO Essential Medicines — World Health Organization essential medicines lists
- National Health Portal (India) — Government of India National Health Portal
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.